Stock Screener · Library
Rein Therapeutics, Inc. financial statement history
Source-linked financial facts for Rein Therapeutics, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 48481000 | USD | 2023-03-20 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 22007000 | USD | 2024-04-15 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 106008000 | USD | 2025-04-07 | 2024 / FY | us-gaap:Assets | 10-K · 0000950170-25-051566 |
| As of 2024-12-31 | 62190000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 24158000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-126385 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 48177000 | USD | 2023-03-20 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 21873000 | USD | 2024-04-15 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 18266000 | USD | 2025-04-07 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-25-051566 |
| As of 2024-12-31 | 13657000 | USD | 2026-03-26 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 4326000 | USD | 2026-03-26 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-126385 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 3600000 | USD | 2023-03-20 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 5194000 | USD | 2024-04-15 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 17338000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-126385 |
| As of 2024-12-31 | 12865000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 3215000 | USD | 2026-03-26 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-126385 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 128000 | USD | 2023-03-20 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 70000 | USD | 2024-04-15 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 19000 | USD | 2025-04-07 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-25-051566 |
| As of 2024-12-31 | 1000 | USD | 2026-03-26 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 0 | USD | 2026-03-26 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-126385 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 4577000 | USD | 2023-03-20 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 3384000 | USD | 2024-04-15 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 7711000 | USD | 2025-04-07 | 2024 / FY | us-gaap:Liabilities | 10-K · 0000950170-25-051566 |
| As of 2024-12-31 | 7798000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 7240000 | USD | 2026-03-26 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-126385 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 4508000 | USD | 2023-03-20 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 3384000 | USD | 2024-04-15 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-044508 |
| As of 2023-12-31 | 4385000 | USD | 2025-04-07 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-25-051566 |
| As of 2024-12-31 | 5749000 | USD | 2026-03-26 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 6180000 | USD | 2026-03-26 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-126385 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 43904000 | USD | 2023-03-20 | 2022 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-23-008767 |
| As of 2022-12-31 | 18623000 | USD | 2025-04-07 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-25-051566 |
| As of 2023-12-31 | 98297000 | USD | 2026-03-26 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-126385 |
| As of 2024-12-31 | 54392000 | USD | 2026-03-26 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-126385 |
| As of 2025-12-31 | 16918000 | USD | 2026-03-26 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-126385 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 0 | USD | 2023-03-20 | 2022 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | 0 | USD | 2024-04-15 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | 0 | USD | 2025-04-07 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2026-03-26 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-26 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001193125-26-126385 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 17008000 | USD | 2023-03-20 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | 17967000 | USD | 2024-04-15 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | 3991000 | USD | 2025-04-07 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | 14248000 | USD | 2026-03-26 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | 11029000 | USD | 2026-03-26 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-126385 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -26605000 | USD | 2023-03-20 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | -27647000 | USD | 2024-04-15 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | -16276000 | USD | 2025-04-07 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | -65112000 | USD | 2026-03-26 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | -50631000 | USD | 2026-03-26 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-126385 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -26164000 | USD | 2023-03-20 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | -27329000 | USD | 2024-04-15 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | -15732000 | USD | 2025-04-07 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | -62883000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | -49871000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-126385 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -5.89 | USD/shares | 2023-03-20 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | -6.02 | USD/shares | 2024-04-15 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | -3.42 | USD/shares | 2025-04-07 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | -3.51 | USD/shares | 2026-03-26 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | -1.96 | USD/shares | 2026-03-26 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-126385 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -23754000 | USD | 2023-03-20 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-23-008767 |
| 2022-01-01 to 2022-12-31 | -24865000 | USD | 2024-04-15 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-044508 |
| 2023-01-01 to 2023-12-31 | -19808000 | USD | 2025-04-07 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-25-051566 |
| 2024-01-01 to 2024-12-31 | -22291000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-126385 |
| 2025-01-01 to 2025-12-31 | -19361000 | USD | 2026-03-26 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-126385 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 157000 | USD | 2023-03-20 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-008767 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1420565
- Ticker in native snapshot
- RNTX
- Reported numeric facts
- 66
- Units present
- USD · USD/shares